Celltrion to contract biological product supply with BMS
Published: 2005-06-27 07:00:00
Updated: 2005-06-27 07:00:00
Bristol-Myer Squibb (BMS), an American gigantic pharmaceutical company, and Celltrion, a Korea bio venture company, signed an agreement on June 22 covering the production and supply of biological products to BMS for 10 years, which estimated about to the total U$2 billion.
Mr. C de Notaristef...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
